Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$62.9M Buy
+429,354
New +$77.8M 0.68% 35
2022
Q1
Sell
-1,257,322
Closed -$110M 26
2021
Q4
$110M Buy
1,257,322
+369,506
+42% +$34.7M 2.06% 21
2021
Q3
$77.4M Buy
887,816
+83,119
+10% +$7.34M 1.81% 21
2021
Q2
$62.6M Buy
804,697
+88,764
+12% +$6.95M 1.68% 22
2021
Q1
$50.2M Buy
715,933
+119,560
+20% +$7.74M 1.75% 20
2020
Q4
$38.6M Buy
596,373
+93,126
+19% +$5.54M 1.68% 19
2020
Q3
$30M Buy
503,247
+128,073
+34% +$7.28M 1.72% 18
2020
Q2
$20.7M Buy
375,174
+64,470
+21% +$3.42M 1.81% 18
2020
Q1
$15M Buy
310,704
+55,427
+22% +$2.86M 1.99% 17
2019
Q4
$13.5M Buy
+255,277
New +$14.1M 1.83% 18

Other funds holding ORCL

Mirova US's ORCL Position: Q2 2026 in Review

Mirova US opened a new position in Oracle (ORCL) in Q2 2026: 429,354 shares worth $62.9M. The stake represents 0.68% of the portfolio and ranks #35 among its holdings. This is a return to the name: Mirova US previously reported a position in ORCL as recently as Q4 2021.

Mirova US first reported a position in ORCL in Q4 2019 and has held it in 10 quarters since. The position peaked at $110M in Q4 2021. 3,518 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Mirova US held 429,354 shares of Oracle worth $62.9M as of Q2 2026.
  • Oracle was a new Mirova US position in Q2 2026.
  • Oracle made up 0.68% of Mirova US's portfolio in Q2 2026, its #35 holding.
  • Mirova US first reported a position in Oracle in Q4 2019 and has held it in 10 quarters since.
  • Mirova US's Oracle position peaked at $110M in Q4 2021.
  • 3,518 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Mirova US's 13F filing for Q2 2026, filed 14 Aug 2026.